Fil LTD Verrica Pharmaceuticals Inc. Transaction History

Fil LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$6.75 - $16.12 $1.22 Million - $2.92 Million	-181,009 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$13.94 - $19.88 $3.3 Million - $4.7 Million	-236,585 Reduced 56.65%	181,009 $2.94 Million
Q2 2018 Aug 10, 2018	BUY	$17.5 - $20.34 $7.31 Million - $8.49 Million	417,594 New	417,594 $8.24 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.